Smith CH - Search Results

1

CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway.

Kyoreva M, Li Y, Hoosenally M, Hardman-Smart J, Morrison K, Tosi I, Tolaini M, Barinaga G, Stockinger B, Mrowietz U, Nestle FO, Smith CH, Barker JN, Di Meglio P. Kyoreva M, et al. Among authors: smith ch. J Invest Dermatol. 2021 Jun;141(6):1553-1563.e3. doi: 10.1016/j.jid.2020.11.024. Epub 2020 Dec 29. J Invest Dermatol. 2021. PMID: 33385398 Free PMC article.

2

Adhesion molecules in allergic inflammation.

Smith CH, Barker JN, Lee TH. Smith CH, et al. Am Rev Respir Dis. 1993 Dec;148(6 Pt 2):S75-8. doi: 10.1164/ajrccm/148.6_Pt_2.S75. Am Rev Respir Dis. 1993. PMID: 7504897 Review.

3

Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin.

Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH. Smith CH, et al. J Immunol. 1993 Sep 15;151(6):3274-82. J Immunol. 1993. PMID: 7690800

4

Cell trafficking and role of adhesion molecules in psoriasis.

Smith CH, Barker JN. Smith CH, et al. Clin Dermatol. 1995 Mar-Apr;13(2):151-60. doi: 10.1016/0738-081x(95)93821-5. Clin Dermatol. 1995. PMID: 7780917 Review. No abstract available.

5

Diffuse plane xanthomatosis and acquired palmoplantar keratoderma in association with myeloma.

Smith CH, Barker JN, Hay RJ. Smith CH, et al. Br J Dermatol. 1995 Feb;132(2):286-9. doi: 10.1111/j.1365-2133.1995.tb05029.x. Br J Dermatol. 1995. PMID: 7888370

6

A case of chromoblastomycosis responding to treatment with itraconazole.

Smith CH, Barker JN, Hay RJ. Smith CH, et al. Br J Dermatol. 1993 Apr;128(4):436-9. doi: 10.1111/j.1365-2133.1993.tb00205.x. Br J Dermatol. 1993. PMID: 8388236

7

Excess melanocytic nevi in children with renal allografts.

Smith CH, McGregor JM, Barker JN, Morris RW, Rigden SP, MacDonald DM. Smith CH, et al. J Am Acad Dermatol. 1993 Jan;28(1):51-5. doi: 10.1016/0190-9622(93)70008-h. J Am Acad Dermatol. 1993. PMID: 8425970

8

Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.

Smith CH, Allen MH, Groves RW, Barker JN. Smith CH, et al. Br J Dermatol. 1998 Aug;139(2):239-46. doi: 10.1046/j.1365-2133.1998.02360.x. Br J Dermatol. 1998. PMID: 9767237

9

A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis.

Smith CH, Jackson K, Chinn S, Angus K, Barker JN. Smith CH, et al. Clin Exp Dermatol. 2000 Nov;25(8):580-3. doi: 10.1046/j.1365-2230.2000.00710.x. Clin Exp Dermatol. 2000. PMID: 11167965 Clinical Trial.

10

Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.

Chew AL, Bennett A, Smith CH, Barker J, Kirkham B. Chew AL, et al. Among authors: smith ch. Br J Dermatol. 2004 Aug;151(2):492-6. doi: 10.1111/j.1365-2133.2004.06105.x. Br J Dermatol. 2004. PMID: 15327561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters